{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:12:46Z","timestamp":1789985566966,"version":"4.0.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Urinary tract infection (UTI) is common in pregnant women. The selection of anti-infection plans during pregnancy must take into account the dual factors of patient pregnancy status and urinary tract infection anti-infection treatment, as well as the efficacy, cost, risk, and potential adverse reactions associated with each method applied to individual patients. Consequently, there are numerous drugs from which to choose; presently, there is no unified conclusion regarding the choice of drug therapy, and there is a lack of long-term drug treatment for UTI during pregnancy. Our objective is to investigate the actual drug treatment patterns of UTI patients during pregnancy in China over the past 5\u00a0years, with a particular emphasis on the trend and rationality of antibiotic use in these patients over the past 5\u00a0years.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> We conducted a cross-sectional analysis of data from a China Medical Association-supervised hospital prescription analysis cooperation initiative. From January 2018 to December 2022, the information is extracted from prescriptions\/medical orders of patients with UTI during pregnancy. Using a primary anatomical therapeutic chemistry (ATC) classification code and the US Food and Drug Administration (FDA) classification, we quantified the frequency of drug use and drug types. We also calculated the prevalence of the most frequently prescribed antibacterial medications and assessed the efficacy of anti-infection plans based on drug labels and guidelines.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among the 563 patients included in this research, Chengdu (36.59%), Guangzhou (27.72%), and Shanghai (8.70%) were the top three cities. Over the course of 5\u00a0years, the average age was 29.60% \u00b1 6.59 years, with approximately 60.21% of women between the ages of 25 and 34. Each patient\u2019s primary anti-infection medications were statistically analyzed. Cephalosporins (403, 71.58%), enzyme inhibitors (66, 11.72%), and penicillins (34, 6.04%) were the first few categories, followed by the most commonly used cephalosporins. Cefuroxime, ceftriaxone, and cefdinib, rounded out the top five. Cefoxitin and cefaclor. According to the 5-year change in dosage, cephalosporins have always ranked first. Three of the top five most expensive drugs are cephalosporins, carbapenems, and enzyme inhibitors. Teicoplanin, tigecycline, nifurtel, linezolid, and quinolones ranked among the top five in terms of per-patient drug costs for patients receiving comprehensive treatment drugs.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In the 5\u00a0years of research, the average age of patients who visit a doctor has not increased substantially, but the opportunity cost of female fertility has increased, which has severely impeded the fulfillment of fertility desires. The selection of medications is generally reasonable, and the dosage of the first-line cephalosporins recommended by the guidelines is relatively high in this study. The dosage of furantoin and fosfomycin, which are more prevalent in urinary tract infections, is however relatively low. In addition, some expensive pharmaceuticals may increase patients\u2019 financial burden. On the premise of meeting clinical needs, future research will focus on how to further improve the level of rational drug use in outpatient clinics, attain economical, safe, and effective drug use, and thus reduce the economic burden on patients.<\/jats:p>","DOI":"10.3389\/fphar.2024.1349121","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T09:54:11Z","timestamp":1706522051000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Real world drug treatment models for pregnancy complicated with urinary tract infection in China from 2018 to 2022: a cross-section analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Jing","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaLei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41598-022-05452-z","article-title":"Prevalence and antimicrobial susceptibility pattern of urinary tract infection among pregnant women attending Hargeisa Group Hospital, Hargeisa, Somaliland","volume":"12","author":"Ali","year":"2022","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40545-020-00292-6","article-title":"Patterns of infections and antimicrobial drugs\u2019 prescribing among pregnant women in Saudi Arabia: a cross sectional study","volume":"14","author":"Baraka","year":"2021","journal-title":"J. Pharm. Policy Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2147\/IDR.S258379","article-title":"Bacterial profile and ESBL screening of urinary tract infection among asymptomatic and symptomatic pregnant women attending antenatal care of northeastern Ethiopia region","volume":"13","author":"Belete","year":"2020","journal-title":"Infect. Drug Resist"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/IDR.S250654","article-title":"A systematic review on drug resistant urinary tract infection among pregnant women in developing countries in africa and asia; 2005-2016","volume":"13","author":"Belete","year":"2020","journal-title":"Infect. Drug Resist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"w20236","DOI":"10.4414\/smw.2020.20236","article-title":"Guideline of the Swiss Society of Gynaecology and Obstetrics (SSGO) on acute and recurrent urinary tract infections in women, including pregnancy","volume":"150","author":"Betschart","year":"2020","journal-title":"Swiss Med. Wkly."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e023592","DOI":"10.1136\/bmjopen-2018-023592","article-title":"Prevalence of respiratory bacterial infections in people with lower respiratory tract infections in Africa: the BARIAFRICA systematic review and meta-analysis protocol","volume":"8","author":"Bigna","year":"2018","journal-title":"BMJ Open"},{"key":"B8","volume-title":"European association of Urology guidelines","author":"Bonkat","year":"2018"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A review of antibiotic use in pregnancy","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","article-title":"Practice guidelines for the management of adult community-acquired urinary tract infections","volume":"48","author":"Caron","year":"2018","journal-title":"M\u00e9d. Mal. Infect."},{"key":"B11","first-page":"2827","article-title":"Consensus among Chinese experts in the diagnosis and treatment of female urinary tract infections","volume":"97","year":"2017","journal-title":"Natl. Med. J. China"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jac\/46.suppl_1.29","article-title":"Which antibiotics are appropriate for treating bacteriuria in pregnancy?","volume":"46","author":"Christensen","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.3390\/jcm11237226","article-title":"Which antibiotic for urinary tract infections in pregnancy? A literature review of international guidelines","volume":"11","author":"Corrales","year":"2022","journal-title":"J. Clin. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.eimc.2016.11.005","article-title":"Executive summary of the diagnosis and treatment of urinary tract infection: guidelines of the Spanish society of clinical microbiology and infectious diseases (SEIMC)","volume":"35","author":"De Cueto","year":"2017","journal-title":"Infecc. Microbiol. Clin."},{"key":"B15","first-page":"713","article-title":"Urinary tract infections during pregnancy","volume":"61","author":"Delzell","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6551526","DOI":"10.1155\/2021\/6551526","article-title":"Prevalence of urinary tract infection and its associated factors among pregnant women in Ethiopia: a systematic review and meta-analysis","volume":"2021","author":"Getaneh","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ucl.2015.05.004","article-title":"Urinary tract infection and bacteriuria in pregnancy","volume":"42","author":"Glaser","year":"2015","journal-title":"Urol. Clin. N. Am."},{"key":"B18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/jcph.139","article-title":"Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations","volume":"53","author":"Goldberg","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD007855","DOI":"10.1002\/14651858.CD007855.pub2","article-title":"Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy","volume":"2010","author":"Guinto","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B21","first-page":"213","article-title":"Risk factors of urinary tract infection in pregnancy","volume":"60","author":"Haider","year":"2010","journal-title":"JPMA J. Pak. Med. Assoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.AOG.0000149154.96285.a0","article-title":"Acute pyelonephritis in pregnancy","volume":"105","author":"Hill","year":"2005","journal-title":"Obstetrics Gynecol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3969\/j.issn.1001-568X.2004.08.037","article-title":"A survey on the situation of unmarried married women of childbearing age in five cities of China","volume":"2004","author":"Hu","year":"2004","journal-title":"Chin. Prim. Health Care"},{"key":"B24","unstructured":"Royal college of physicians of Ireland and the clinical strategy and programmes division, Health service executive clinical practice guideline management of urinary tract infections in pregnancy2018"},{"key":"B25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/01443615.2017.1370579","article-title":"Urinary tract infection during pregnancy: current concepts on a common multifaceted problem","volume":"38","author":"Kalinderi","year":"2018","journal-title":"J. Obstetrics Gynaecol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s40265-013-0143-y","article-title":"Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria","volume":"73","author":"Keating","year":"2013","journal-title":"Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5414\/NHX1862","article-title":"Interdisziplin\u00e4re AWMF S3-Leitlinie: epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten","volume":"46","author":"Kranz","year":"2017","journal-title":"Nieren-Und Hochdruckkrankh."},{"key":"B28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12978-021-01298-2","article-title":"Prevalence and associated factors of infertility among 20-49\u00a0year old women in Henan Province, China","volume":"18","author":"Liang","year":"2021","journal-title":"Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0123-9392(13)70719-7","article-title":"Infecciones del tracto urinario bajo en adultos y embarazadas: consenso para el manejo emp\u00edrico","volume":"17","author":"Martinez","year":"2014","journal-title":"Infectio"},{"key":"B30","first-page":"1","volume-title":"Pharmacopoeia of the China: instructions for clinical drug use","year":"2010"},{"key":"B31","unstructured":"Urinary tract infection (lower): antimicrobial prescribing2022"},{"key":"B32","unstructured":"Pyelonephritis (acute): antimicrobial prescribing2022"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1756287218814382","DOI":"10.1177\/1756287218814382","article-title":"Risk factors and predisposing conditions for urinary tract infection","volume":"11","author":"Storme","year":"2019","journal-title":"Ther. Adv. Urology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4834396","DOI":"10.1155\/2019\/4834396","article-title":"Bacterial aetiologies of lower respiratory tract infections among adults in Yaound\u00e9 Cameroon","volume":"2019","author":"Tchatchouang","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD000491","DOI":"10.1002\/14651858.CD000491.pub2","article-title":"Duration of treatment for asymptomatic bacteriuria during pregnancy","volume":"2015","author":"Widmer","year":"2015","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1349121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T09:54:16Z","timestamp":1706522056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1349121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":34,"alternative-id":["10.3389\/fphar.2024.1349121"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1349121","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"article-number":"1349121"}}